Since then, in vitro and in vivo studies recognized the potential of GDNF as a protective and restorative factor for DA neurons and, consequently, as a promising therapeutic agent in Parkinson’s disease (PD) [2,3,4,5,6,7]. This evidence concerns the gene GDNF and Parkinson disease.